News & Press Releases

TORONTO – Mintz continues to grow in Canada and extend its market-leading life sciences and private equity capabilities. The addition of Partners Matthew Atkey and Brad Tartick, Special Counsel Bernard Kwasniewski and Of Counsel Matthew Imrie, will bolster Mintz’s premier capital markets, M&A, funds, and employment and pensions-focused practices.

The Globe and Mail featured the arrival of Partners Matthew Atkey and Brad Tartick, Special Counsel Bernard Kwasniewski and Of Counsel Matthew Imrie who will join Michael Akkawi, Cheryl Reicin, Mitch Frazer, Eric Foster, and Lee Johnson in the firm's Toronto office.

The arrival of Partners Matthew Atkey and Brad Tartick, Special Counsel Bernard Kwasniewski and Of Counsel Matthew Imrie was covered by The Deal. The article stated, "The new attorneys strengthen the firm’s life sciences and private equity capabilities in its Toronto office."

Member Frank Gerratana spoke to Insider about the growing use of AI technology and how this will impact copyright laws.

Law.com covered the arrival of Toronto Partners Matthew Atkey and Brad Tartick, Special Counsel Bernard Kwasniewski and Of Counsel Matthew Imrie.

NEW YORK – Mintz represented the syndicate of underwriters led by William Blair & Company, L.L.C., in the public offering of 17,242,000 shares of common stock of Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, at an initial offering price of $14.50 per share.